What makes Feramax^®  different from other iron supplements, and why is it important?

Yes! Feramax^® Pd Therapeutic 150 is then only polydextrose-iron complex (PDIC) in Canada.

FeraMAX^® was also the original polysaccharide-iron complex (PIC) in Canada. The original PIC was from Schwartz Pharma, which developed, manufactured, and launched the first PIC under the brand name Niferex. Schwartz ultimately transferred its manufacturing rights of this PIC molecule to a third party and Niferex was subsequently discontinued in Canada.

BioSyent Pharma contracted the manufacturing exclusivity of this PIC molecule and then continued to manufacture the product under a new brand, namely FeraMAX^®. Consequently, as it is derived directly from the original manufacturing process of PIC, FeraMAX^® is the original PIC molecule.

Currently FeraMAX^® is the only iron supplement manufactured in a North American FDA approved facility.

Subsequently, there have been several “Branded Generic” PICs launched in Canada trying to leverage the success of this formulation that provides less side effects and convenient once a day dosing.

Most iron supplements are ferrous (iron) salts. Feramax^® Pd Therapeutic 150 is a polydextrose-iron complex. This formulation provides a well tolerated high-dosage of elemental iron. It is also the only iron supplement that is Vegan Certified.

Feramax^® Pd Therapeutic 150 is positively charged and soluble at pH < 4.0. This solubility at low pH may be associated with improved absorption.
X-ray diffraction analysis shows that polysaccharide-iron complexes have a ferrihydrite (β-FeOOH) structure that closely resembles the structure of ferritin, the natural intracellular protein that binds iron in duodenal cells.

The fact that the polydextrose-iron complex closely resembles endogenous carriers of iron could account for its high bioavailability and reduced side effects.